相似文献
1
JP-1302: a new tool to shed light on the roles of alpha2C-adrenoceptors in brain.
Br J Pharmacol. 2007 Feb;150(4):381-2. doi: 10.1038/sj.bjp.0707007. Epub 2007 Jan 15.
2
Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
Br J Pharmacol. 2007 Feb;150(4):391-402. doi: 10.1038/sj.bjp.0707005. Epub 2007 Jan 15.
3
Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
Basic Clin Pharmacol Toxicol. 2013 Oct;113(4):239-49. doi: 10.1111/bcpt.12090. Epub 2013 Jun 20.
4
alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
J Pharmacol Exp Ther. 1999 Jun;289(3):1286-92.
5
Autoradiographic characterization of alpha(2C)-adrenoceptors in the human striatum.
Synapse. 2008 Jul;62(7):508-15. doi: 10.1002/syn.20520.
6
α2C-Adrenoceptors modulate L-DOPA uptake in opossum kidney cells and in the mouse kidney.
Am J Physiol Renal Physiol. 2012 Oct;303(7):F928-38. doi: 10.1152/ajprenal.00217.2011. Epub 2012 Aug 1.
7
Alpha-2c-adrenergic receptors contribute to basal nasal patency in the anesthetized cat.
Pharmacology. 2010;85(5):259-63. doi: 10.1159/000284581. Epub 2010 Apr 7.
8
9
Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions.
J Neurochem. 2005 Sep;94(6):1559-69. doi: 10.1111/j.1471-4159.2005.03305.x. Epub 2005 Jul 5.
引用本文的文献
1
A proteome-wide atlas of drug mechanism of action.
Nat Biotechnol. 2023 Jun;41(6):845-857. doi: 10.1038/s41587-022-01539-0. Epub 2023 Jan 2.
2
Structural determinants of the alpha2 adrenoceptor subtype selectivity.
J Mol Graph Model. 2011 Aug;29(8):1030-8. doi: 10.1016/j.jmgm.2011.04.011. Epub 2011 May 6.
3
Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptors.
Neuropharmacology. 2008 May;54(6):944-53. doi: 10.1016/j.neuropharm.2008.02.002. Epub 2008 Feb 10.
本文引用的文献
1
Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
Br J Pharmacol. 2007 Feb;150(4):391-402. doi: 10.1038/sj.bjp.0707005. Epub 2007 Jan 15.
2
Guide to receptors and channels, 2nd edition.
Br J Pharmacol. 2006 Mar;147 Suppl 3(Suppl 3):S1-168. doi: 10.1038/sj.bjp.0706651.
3
Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.
Psychopharmacology (Berl). 2005 Feb;177(4):373-80. doi: 10.1007/s00213-004-1970-z. Epub 2004 Sep 24.
4
The alpha2C-adrenoceptor modulates GABA release in mouse striatum.
Brain Res Mol Brain Res. 2003 Apr 10;112(1-2):24-32. doi: 10.1016/s0169-328x(03)00026-3.
5
Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice.
Neuroscience. 2002;109(4):819-26. doi: 10.1016/s0306-4522(01)00531-0.
6
OPC-28326, a selective femoral vasodilator, is an alpha2C-adrenoceptor-selective antagonist.
J Pharmacol Exp Ther. 2001 Nov;299(2):652-8.
7
In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors.
J Pharmacol Exp Ther. 2000 Apr;293(1):1-7.
8
Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels.
Mol Psychiatry. 1999 Sep;4(5):443-52. doi: 10.1038/sj.mp.4000543.
9
Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns.
Neuroscience. 1999;88(4):1187-98. doi: 10.1016/s0306-4522(98)00306-6.
10
Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension.
Hypertension. 1999 Jan;33(1):14-7. doi: 10.1161/01.hyp.33.1.14.
Zotero 插件